One of the great privileges of serving as ACCP president this year has been hearing from many members across our Practice and Research Networks (PRNs). Through newsletters, community discussions, presentations, and informal conversations, I am continually reminded of the extraordinary work occurring across the College. Every PRN represents a community of clinicians, scientists, educators, students, and trainees who are advancing knowledge and improving patient care in meaningful ways.

What has struck me most in these interactions is a common thread that runs through so much of the work our members are doing: the prevention of harm.

Across practice environments, including critical care units, ambulatory care clinics, community pharmacies, specialty/subspecialty practices, and health systems, clinical pharmacists are working every day to prevent medication-related harm. You are identifying risks before they reach the patient, optimizing therapy to avoid complications, redesigning medication use systems to make care safer, and generating research that informs better decisions. This work is occurring quietly but powerfully in hospitals, clinics, laboratories, classrooms, health systems, and the pharmaceutical industry.

Yet the very nature of preventing harm creates a paradox:

• When we prevent harm successfully, nothing dramatic happens.
• A medication error is intercepted before it reaches the patient.
• A harmful interaction is avoided.
• A dose adjustment prevents toxicity.
• A system redesign eliminates a risk before anyone is injured.

From the outside, these successes can be difficult to see. Unlike treating disease, preventing harm often leaves no visible trace. But those of us in clinical pharmacy know that behind every “non-event” lies thoughtful clinical reasoning, deep pharmacotherapy expertise, and carefully designed systems of care.

In many ways, the most impactful work we do is invisible.

This reality makes the role of the ACCP PRNs particularly important. PRNs are where ideas originate, collaborations begin, and innovations take shape. Within these networks, members share clinical experiences, test new approaches, conduct research, develop educational programming, and mentor the next generation of clinical pharmacists. PRNs are not just professional communities; they are engines for advancing practice and research across our profession.

Because of this, PRNs play a critical role in helping our profession accomplish something essential: making the invisible visible.

Through PRN initiatives, publications, webinars, collaborative projects, conference programming, and shared expertise, we illuminate the work of clinical pharmacists in improving medication safety and patient outcomes. We transform individual experiences into shared knowledge. We convert local innovation into broader progress for the profession.

When the work of clinical pharmacists becomes visible, it changes how others understand our role. Patients better appreciate the impact of medication optimization. Health systems recognize the value of clinical pharmacy services. Policymakers see the importance of integrating medication experts into care teams. Future clinical pharmacists see a profession filled with opportunity and purpose.

Visibility also shapes how the public understands health care. The stories told about health professionals, whether in research publications, policy discussions, or the narratives that reach patients and communities, help define who is seen as essential to care. When clinical pharmacists are visible in these conversations, it reinforces the critical role of medication experts in improving outcomes and preventing harm.

In this sense, the ability of PRNs to connect, amplify, and share the work of our members may be one of our profession’s greatest strengths.

As I continue to hear from PRN leaders and members, I am inspired by the creativity and commitment I see across the College. Whether developing new practice models, advancing research initiatives, developing opinion papers, producing educational programming, or mentoring students and trainees, PRNs remain at the center of ACCP’s mission to advance clinical pharmacy practice and research.

I encourage each PRN to reflect on how the work occurring within your network contributes to preventing medication-related harm and improving patient care. Just as important, I encourage you to think about how we can share these stories more broadly. The impact of clinical pharmacists deserves to be seen, understood, and valued, not only within our profession but also across the health care system and by the patients we serve.

One of the best opportunities to highlight this work will be at the 2026 ACCP Annual Meeting in Salt Lake City, Utah, this October. The Annual Meeting provides an important forum for PRNs to showcase innovations in clinical practice and research, foster collaborations, and engage members at every stage of their careers. PRN focus sessions, networking opportunities, and research presentations all help bring the work of our members to a larger stage.

I hope many of you will join us in Salt Lake City to share your work, learn from colleagues, and continue the conversations that drive our profession forward.

Finally, I want to thank each of you for the work you do within your PRNs and your practices. Every time you prevent a medication-related harm, improve a system of care, mentor a trainee, or contribute to new knowledge, you are advancing clinical pharmacy and improving the lives of patients.

Much of this work may never appear in headlines or dramatic moments, but it is precisely this quiet prevention that protects patients every day.

And it matters deeply.

Together, through the strength of our PRNs, we can ensure that the impact of clinical pharmacists and the harm we prevent every day become increasingly visible.

I look forward to continuing this journey with all of you and to seeing many of you in Salt Lake City this fall.